宫颈癌每日在线自适应放疗联合缩小PTV边界的急性毒性及剂量学前瞻性研究
该前瞻性单臂研究纳入27例I-III期宫颈癌患者,接受每日iCBCT引导的在线自适应放疗(oART,处方50.4 Gy/28次)同步每周化疗后近距离治疗。结果显示所有分次均选用自适应计划,靶区覆盖及危及器官剂量均优于预定计划,未出现≥4级急性毒性,患者报告结局亦支持低毒性。
要点
- 27例宫颈癌患者每日iCBCT引导oART,PTV-U采用10mm、其他PTV采用5mm边界。
- 所有分次均选用自适应计划,靶区覆盖及OAR剂量均优于预定计划。
- 无≥4级急性毒性,1-3级胃肠毒性分别为26%、19%、4%,仅2例(7%)出现1级泌尿毒性。
核心结论
- 每日oART在宫颈癌患者中观察到剂量学获益,且临床医生和患者报告的急性毒性发生率均较低。
研究设计与样本
- 所有患者接受每日iCBCT引导oART(处方50.4 Gy/28次)同步每周化疗后近距离治疗。
- PTV-U采用10mm均匀边界,其他PTV采用5mm边界;记录每分次剂量学结果,并在治疗前、治疗中每周、治疗后1个月和3个月评估急性毒性。
主要发现
- 平均总治疗时间为22分54秒,所有分次均选用自适应计划。
- 自适应计划相比预定计划显示更优的靶区覆盖和危及器官剂量学改善。
- 无患者出现≥4级急性毒性;1级、2级、3级急性胃肠毒性分别为26%、19%、4%,其中腹泻最常见。
- 仅观察到2例(7%)1级急性泌尿毒性。
- 患者报告结局显示oART开始后功能子量表平均标准分显著下降、症状子量表/条目显著升高,多数量表在1个月随访时恢复至基线平均分。
关键数值与推荐
- 处方剂量50.4 Gy/28次,同步每周化疗后近距离治疗。
- PTV-U边界10mm,其他PTV边界5mm。
- 1级、2级、3级急性胃肠毒性分别为26%、19%、4%;1级急性泌尿毒性2例(7%)。
临床怎么用
- 宫颈癌每日iCBCT引导oART采用缩小PTV边界(PTV-U 10mm、其他PTV 5mm)可观察到剂量学获益和低急性毒性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate acute toxicity and dosimetric outcomes in cervical cancer treated with daily iterative cone beam computed tomography (iCBCT) guided online adaptive radiation therapy (oART) using reduced planning target volume (PTV) margin. METHODS AND MATERIALS: From February 2023 to November 2023, 27 patients with stages I to III cervical cancer were prospectively enrolled in this study. All patients received daily iCBCT guided oART (prescribed 50.4 Gy in 28 fractions) with concurrent weekly chemotherapy followed by brachytherapy. A uniform 10-mm margin was used to cover more variable uterus (PTV-U), and 5-mm margin was used for other PTV. The dosimetric results for each oART fraction were recorded. Both clinician- and patient-reported acute toxicities were assessed before treatment, weekly during treatment, 1 month and 3 months after treatment. RESULTS: The average total treatment time was 22 minutes and 54 seconds, and the adapted plan was selected for all fractions. The adapted plans showed superior coverage for the target volume and dosimetric improvement of organs at risk compared with the scheduled plan. Overall, no patient had grade ≥ 4 acute toxicities. Grades 1, 2, and 3 acute gastrointestinal toxicity were 26%, 19%, and 4%, respectively, among which diarrhea was the most common. Only grade 1 acute genitourinary toxicity was observed in 2 cases (7%). The low incidence of acute toxicity was supported by patient-reported outcome data, which showed significant decreases in mean standard scores on function subscales and significant increases on symptom subscales/items following the initiation of oART. Most of these scales returned to baseline average scores by the 1-month follow-up. CONCLUSIONS: This prospective study of daily oART in patients with cervical cancer observed dosimetric benefits and a low incidence of acute toxicity, both in clinician- and patient-reported outcome measurements.
引用
- Wang G, Chen Y, Wang Z, et al. A Prospective Single-Arm Study of Daily Online Adaptive Radiation Therapy for Cervical Cancer with Reduced Planning Target Volume Margin: Acute Toxicity and Dosimetric Outcomes. Int J Radiat Oncol Biol Phys. 2025. PMID: 40180059. doi:10.1016/j.ijrobp.2025.03.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。